Skip to content
healthcare.dev

Methylphenidate Extended-Release

NDC 62542-350, methylphenidate extended-release, tablet, orally disintegrating, from Neos Therapeutics, LP.

Product NDC
62542-350
Status
Listed
Labeler
Neos Therapeutics, LP
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA205489
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62542-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE25.9 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
62542-350-316254203503130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62542-350-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2fec19b-6610-4ce0-8e60-f8218a11f62f

Use it

Look up 62542-350 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62542-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62542-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.